Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-6,056
Closed -$596K 770
2025
Q2
$596K Buy
+6,056
New +$573K 0.01% 530
2021
Q3
Sell
-9,773
Closed -$2.39M 672
2021
Q2
$2.39M Sell
9,773
-727
-7% -$191K 0.08% 229
2021
Q1
$2.78M Sell
10,500
-1,538
-13% -$434K 0.09% 193
2020
Q4
$3.53M Sell
12,038
-937
-7% -$240K 0.12% 151
2020
Q3
$3.07M Sell
12,975
-2,216
-15% -$504K 0.11% 153
2020
Q2
$3.02M Sell
15,191
-10,213
-40% -$1.9M 0.12% 155
2020
Q1
$4.66M Sell
25,404
-8,558
-25% -$1.52M 0.18% 135
2019
Q4
$5.67M Sell
33,962
-7,127
-17% -$1.06M 0.18% 148
2019
Q3
$5.38M Sell
41,089
-16,133
-28% -$2.1M 0.18% 152
2019
Q2
$6.95M Sell
57,222
-1,919
-3% -$228K 0.22% 131
2019
Q1
$7.29M Sell
59,141
-8,130
-12% -$1.02M 0.23% 131
2018
Q4
$7.88M Sell
67,271
-55,000
-45% -$6.48M 0.27% 107
2018
Q3
$15.3M Sell
122,271
-5,000
-4% -$552K 0.43% 47
2018
Q2
$10.9M Sell
127,271
-340
-0.3% -$25K 0.5% 73
2018
Q1
$7.7M Buy
127,611
+3,701
+3% +$211K 0.35% 132
2017
Q4
$6.53M Sell
123,910
-3,000
-2% -$158K 0.27% 143
2017
Q3
$7.1M Buy
+126,910
New +$6.71M 0.3% 145

Other funds holding AMED

Hancock Whitney's AMED Position: Q3 2025 in Review

Hancock Whitney sold out of Amedisys (AMED) in Q3 2025, closing a stake of 6,056 shares — an estimated $596K sold.

Hancock Whitney first reported a position in AMED in Q3 2017 and held it in 17 quarters. The position peaked at $15.3M in Q3 2018. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Hancock Whitney reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Hancock Whitney sold 6,056 Amedisys shares in Q3 2025, an estimated $596K.
  • Hancock Whitney first reported a position in Amedisys in Q3 2017 and held it in 17 quarters.
  • Hancock Whitney's Amedisys position peaked at $15.3M in Q3 2018.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Hancock Whitney's 13F filing for Q3 2025, filed 17 Nov 2025.